| 摘要 |
Use of an agent (I) that stimulates production of nitric oxide (NO) or prostacyclin (II), for treatment or prevention of intimal hyperplasia in a blood vessel is new. Also claimed are: (1) implants containing (I), and (2) a device for delivering a therapeutic agent (A) to a blood vessel comprising a body that can be sealed around the vessel and includes (A) which, during use, is in contact with the adventitial surface of the vessel. |
